Clinically recorded heart rate and incidence of 12 coronary,cardiac,cerebrovascular and peripheral arterial diseases in 233,970 men and women: A linked electronic health record study

Abstract

Background

In healthy population cohorts, resting heart rate above 90 bpm is associated with mortality from coronary heart disease, but it is not clear whether associations are present at lower heart rates or whether these associations differ between women.

Methods

The CALIBER resource of linked electronic health records from primary care, hospitalisations, myocardial infarction registry and cause-specific mortality in the UK was used to assess associations between resting heart rate and 12 fatal and non-fatal coronary, cardiac, cerebral and peripheral vascular cardiovascular diseases and death using Cox proportional hazard models.

Results

Among 233,970 patients, 29,690 fatal and non-fatal events occurred. Fully adjusted models showed that resting heart rate was not associated in men or women with cerebrovascular events. In men a resting heart rate of 70–79 bpm (29.1% of all men) versus less than 60 bpm was associated with an increased risk of heart failure (hazard ratio (HR) 1.65, 95% confidence interval (CI) 1.26–2.16), unheralded coronary death (HR 1.65, 95% CI 1.13–2.41), total cardiovascular events (HR 1.22, 95% CI 1.15–1.28) and all-cause mortality (HR 1.39, 95% CI 1.22–1.58). Women with a higher resting heart rate level of 80–89 bpm versus 60 bpm had a higher risk of total cardiovascular disease events (HR 1.17, 95% CI 1.07–1.24) and all-cause mortality (HR 1.21, 95% CI 1.07–1.35) compared to a resting heart rate less than 60 bpm. The risk was also present at higher heart rates (>90 bpm) for heart failure and sudden cardiac death.

Conclusions

A resting heart rate that clinicians currently consider as ‘normal’ in the general population is specifically associated with the incidence of certain major cardiovascular diseases and death, with the risk starting at lower resting heart rate levels in men compared to women. Further research is required to evaluate whether interventions to lower resting heart rate are warranted to prevent disease.

The study is registered at: clinicaltrials.gov (ID: NCT01947361).

Keywords

Heart rate linked electronic health records cardiovascular heart failure sudden death

Get full access to this article

View all access options for this article.

References

Walsh

Topol

Steinhubl

. Novel wireless devices for cardiac monitoring. Circulation 2014; 130: 573–581.

Achten

Jeukendrup

. Heart rate monitoring: Applications and limitations. Sports Med 2003; 33: 517–538.

Coppetti

Brauchlin

Müggler

et al.

Accuracy of smartphone apps for heart rate measurement. Eur J Prev Cardiol 2017; 24: 1287–1293.

Cooney

Vartiainen

Laakitainen

et al.

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159: 612–619; e3.

Jouven

Empana

Schwartz

et al.

Heart rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951–1958.

Kristal-Boneh

Silber

Harari

et al.

The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21: 116–124.

Tverdal

Hjellvik

Selmer

. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379 843 men and women aged 40–45 years. Eur Heart J 2008; 29: 2772–2781.

Hsia

Larson

Ockene

et al.

Resting heart rate as a low tech predictor of coronary events in women: Prospective cohort study. BMJ 2009; p.b219: 338–338.

Woodward

Webster

Murakami

et al.

The association between resting heart rate, cardiovascular disease and mortality: Evidence from 112,680 men and women in 12 cohorts. Eur J Prev Cardiol 2014; 21: 719–726.

10.

Jensen

Suadicani

Hein

et al.

Elevated resting heart rate, physical fitness and all-cause mortality: A 16-year follow-up in the Copenhagen Male Study. Heart 2013; 99: 882–887.

11.

Palatini

Casiglia

Julius

et al.

High heart rate: A risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585–592.

12.

Denaxas

George

Herrett

et al.

Data resource profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012; 41: 1625–1638.

13.

George

Rapsomaniki

Pujades-Rodriguez

et al.

How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circulation 2015; 132: 1320–1328.

14.

Rapsomaniki

Timmis

George

et al.

Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899–1911.

15.

Pujades-Rodriguez

George

Shah

et al.

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1,937,360 people in England: Lifetime risks and implications for risk prediction. Int J Epidemiol 2015; 44: 129–141.

16.

Walley

Mantgani

. The UK General Practice Research Database. Lancet 1997; 350: 1097–1099.

17.

Herrett

Smeeth

Walker

et al.

The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010; 96: 1264–1267.

18.

Centre TH and SCI. Hospital Episodes Statistics (HES). 2011. Available from: http://www.hesonline.nhs.uk/Ease/servlet/ ContentServer?siteID=1937.

19.

Office for National Statistics. Mortality Statistics: Metadata 2010 Statistics. London. (2011, accessed 14 November 2012).

20.

Gallagher A, Puri S and van Staa T. Linkage of the General Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Safety 2011; 20: S230–S367. Available at: https://insights.ovid.com/pharmacoepidemiology-drug-safety/pads/2011/08/001/528-linkage-general-practice-research-database/528/01445491.

21.

Herrett

Gallagher

Bhaskaran

et al.

Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827–836.

22.

Herrett

Shah

Boggon

et al.

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: Cohort study. BMJ 2013; 346: f2350–f2350.

23.

Government DoCaL. English IMD 2010 data English indices of deprivation 2010 (2011) [Government DoCaL]. www.communities.gov.uk/publications/corporate/statistics/indices 2010 (2011, accessed).

24.

Zhou

Stamler

Dennis

et al.

Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: The INTERMAP study. J Human Hypertens 2003; 17: 623–630.

25.

Benetos

Rudnichi

Thomas

et al.

Influence of heart rate on mortality in a French population: Role of age, gender, and blood pressure. Hypertension 1999; 33: 44–52.

26.

Nanchen

Leening

MJG

Locatelli

et al.

Resting heart rate and the risk of heart failure in healthy adults: The Rotterdam Study. Circulation: Heart Fail 2013; 6: 403–410.

27.

Pfister

Michels

Sharp

et al.

Resting heart rate and incident heart failure in apparently healthy men and women in the EPIC-Norfolk study. Eur J Heart Fail 2012; 14: 1163–1170.

28.

Lechat

Hulot

J-S

Escolano

et al.

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103: 1428–1433.

29.

Dyer

Persky

Stamler

et al.

Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736–749.

30.

Jouven

Empana

J-P

Schwartz

et al.

Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951–1958.

31.

Jouven

Zureik

Desnos

et al.

Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 2001; 50: 373–378.

32.

Vaillant

Dehina

Mazzadi

et al.

Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: Role of myocyte structure and myocardial perfusion. Resuscitation 2011; 82: 1092–1099.

33.

Tofler

Massaro

Levy

et al.

Increased heart rate is associated with a prothrombotic state: the Framingham Heart Study. Eur J Prev Cardiol 2017; 24: 382–388.

34.

Tardif

J-C

. Heart rate and atherosclerosis. Eur Heart J Suppl 2009; 11(Suppl. D): D8–D12.

35.

Kannel

Paffenbarger

et al.

Heart rate and cardiovascular mortality: The Framingham study. Am Heart J 1987; 113: 1489–1494.

36.

Shaper

Wannamethee

Macfarlane

et al.

Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993; 70: 49–55.

37.

Walters

Yean Leng

. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol 1970; 77: 1007–1012.

38.

Fox K, Ford I, Steg P, et al. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014; 371: 1091–1099.

39.

Eppinga

Hagemeijer

Burgess

et al.

Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality. Nature Genet 2016; 48: 1557–1557.

40.

Cooney

Dudina

Graham

. Value and limitations of existing scores for the assessment of cardiovascular risk: A review for clinicians. J Am Coll Cardiol 2009; 54: 1209–1227.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.77 MB